COGT · NASDAQ
Cogent Biosciences (COGT) Stock Price & Fundamentals
Cogent Biosciences (COGT) closed at $542.70 on Oct 9, 2026, down 1.04% from the previous close of $548.38.
Share price, past year
1Y +22.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $542.70 |
| Sep 30, 2026 | $546.85 |
| Aug 31, 2026 | $548.16 |
| Jul 31, 2026 | $495.76 |
| Jun 30, 2026 | $467.68 |
| May 29, 2026 | $470.05 |
| Apr 30, 2026 | $482.80 |
| Mar 31, 2026 | $479.38 |
| Feb 27, 2026 | $460.50 |
| Jan 30, 2026 | $465.87 |
| Dec 31, 2025 | $456.65 |
| Nov 28, 2025 | $437.54 |
| Oct 31, 2025 | $459.44 |
Key statistics
- Market cap
- $93.13B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.16
- Revenue (TTM)
- —
- Net income (TTM)
- −$377.18M
- Shares outstanding
- 171.6M
- Dividend yield
- —
- 52-week range
- $431.32 – $569.59
Cogent Biosciences's market cap is $93.13B, based on a share price of $542.70 and 171.6M shares outstanding as of Jun 30, 2026.
Financials
Cogent Biosciences reported revenue of $7.87M for fiscal 2020, down 65.02% from fiscal 2019.
Cogent Biosciences reported a net loss of $328.94M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $7.87M | −65.0% | −$74.81M | −950.4% | −$16.17 | — |
| FY2019ended Dec 31, 2019 | $22.50M | +131.1% | −$31.83M | −141.5% | −$4.18 | −$41.55M |
| FY2018ended Dec 31, 2018 | $9.73M | +16.4% | −$34.53M | −354.8% | −$1.39 | −$33.04M |
| FY2017ended Dec 31, 2017 | $8.36M | — | −$25.49M | −304.9% | −$2.51 | −$26.75M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2020ended Dec 31, 2020 | $0.00 | — | — |
| Q3 FY2020ended Sep 30, 2020 | $312.00K | — | — |
| Q2 FY2020ended Jun 30, 2020 | $528.00K | — | — |
| Q1 FY2020ended Mar 31, 2020 | $7.03M | — | — |
| Q4 FY2019ended Dec 31, 2019 | $15.29M | — | — |
| Q3 FY2019ended Sep 30, 2019 | $1.02M | — | — |
| Q2 FY2019ended Jun 30, 2019 | $3.14M | — | — |
| Q1 FY2019ended Mar 31, 2019 | $3.05M | — | — |
Company profile
- Name
- Cogent Biosciences, Inc.
- Ticker
- COGT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 180 Third Avenue, 4th Floor, Waltham, MA
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001622229
Recent SEC filings
- Sep 2, 2026
- Aug 10, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jun 11, 2026
- May 5, 2026
- May 5, 2026
- Feb 17, 2026
Frequently asked questions
What is Cogent Biosciences's stock price?
Cogent Biosciences (COGT) closed at $542.70 on Oct 9, 2026, down 1.04% from the previous close of $548.38.
What is Cogent Biosciences's market cap?
Cogent Biosciences's market cap is $93.13B, based on a share price of $542.70 and 171.6M shares outstanding as of Jun 30, 2026.
How much revenue does Cogent Biosciences make?
Cogent Biosciences reported revenue of $7.87M for fiscal 2020, down 65.02% from fiscal 2019.
Does Cogent Biosciences pay a dividend?
Cogent Biosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cogent Biosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures